nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluridine—Cladribine—multiple sclerosis	0.348	1	CrCtD
Trifluridine—Nucleic Acid Synthesis Inhibitors—Azathioprine—multiple sclerosis	0.233	0.608	CiPCiCtD
Trifluridine—Nucleoside Analog—Azathioprine—multiple sclerosis	0.15	0.392	CiPCiCtD
Trifluridine—Idoxuridine—Cladribine—multiple sclerosis	0.0483	0.229	CrCrCtD
Trifluridine—Telbivudine—Cladribine—multiple sclerosis	0.0483	0.229	CrCrCtD
Trifluridine—Floxuridine—Cladribine—multiple sclerosis	0.044	0.208	CrCrCtD
Trifluridine—Pentostatin—Cladribine—multiple sclerosis	0.044	0.208	CrCrCtD
Trifluridine—TYMS—Methotrexate—multiple sclerosis	0.0373	0.853	CbGbCtD
Trifluridine—Decitabine—Cladribine—multiple sclerosis	0.0264	0.125	CrCrCtD
Trifluridine—SLC22A6—Methotrexate—multiple sclerosis	0.00643	0.147	CbGbCtD
Trifluridine—Corneal oedema—Dexamethasone—multiple sclerosis	0.00067	0.0974	CcSEcCtD
Trifluridine—Corneal oedema—Betamethasone—multiple sclerosis	0.00067	0.0974	CcSEcCtD
Trifluridine—Hyperaemia—Betamethasone—multiple sclerosis	0.000465	0.0676	CcSEcCtD
Trifluridine—Hyperaemia—Dexamethasone—multiple sclerosis	0.000465	0.0676	CcSEcCtD
Trifluridine—Cladribine—RRM1—multiple sclerosis	0.00046	0.864	CrCbGaD
Trifluridine—TK1—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000451	0.163	CbGpPWpGaD
Trifluridine—Intraocular pressure increased—Prednisolone—multiple sclerosis	0.000382	0.0556	CcSEcCtD
Trifluridine—Intraocular pressure increased—Triamcinolone—multiple sclerosis	0.000352	0.0511	CcSEcCtD
Trifluridine—Intraocular pressure increased—Methylprednisolone—multiple sclerosis	0.000351	0.051	CcSEcCtD
Trifluridine—Intraocular pressure increased—Betamethasone—multiple sclerosis	0.000319	0.0464	CcSEcCtD
Trifluridine—Intraocular pressure increased—Dexamethasone—multiple sclerosis	0.000319	0.0464	CcSEcCtD
Trifluridine—TYMP—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000312	0.113	CbGpPWpGaD
Trifluridine—Intraocular pressure increased—Prednisone—multiple sclerosis	0.000278	0.0404	CcSEcCtD
Trifluridine—TK1—E2F transcription factor network—RRM1—multiple sclerosis	0.000239	0.0863	CbGpPWpGaD
Trifluridine—Vision blurred—Fingolimod—multiple sclerosis	0.000227	0.033	CcSEcCtD
Trifluridine—TK1—Nucleotide metabolism—RRM1—multiple sclerosis	0.000227	0.0819	CbGpPWpGaD
Trifluridine—TK1—Azacitidine—Cladribine—multiple sclerosis	0.000223	0.187	CbGdCrCtD
Trifluridine—TK1—nervous system—multiple sclerosis	0.000217	0.108	CbGeAlD
Trifluridine—TK1—central nervous system—multiple sclerosis	0.000209	0.104	CbGeAlD
Trifluridine—Stinging—Prednisolone—multiple sclerosis	0.000208	0.0302	CcSEcCtD
Trifluridine—Stinging—Triamcinolone—multiple sclerosis	0.000191	0.0278	CcSEcCtD
Trifluridine—Stinging—Betamethasone—multiple sclerosis	0.000173	0.0252	CcSEcCtD
Trifluridine—Stinging—Dexamethasone—multiple sclerosis	0.000173	0.0252	CcSEcCtD
Trifluridine—TK1—brain—multiple sclerosis	0.000166	0.0822	CbGeAlD
Trifluridine—TYMS—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00016	0.0578	CbGpPWpGaD
Trifluridine—TYMP—Nucleotide metabolism—RRM1—multiple sclerosis	0.000157	0.0567	CbGpPWpGaD
Trifluridine—TYMP—medulla oblongata—multiple sclerosis	0.000154	0.0763	CbGeAlD
Trifluridine—TYMP—midbrain—multiple sclerosis	0.00014	0.0697	CbGeAlD
Trifluridine—TYMP—spinal cord—multiple sclerosis	0.000137	0.068	CbGeAlD
Trifluridine—Dry eye—Betamethasone—multiple sclerosis	0.00013	0.0188	CcSEcCtD
Trifluridine—Dry eye—Dexamethasone—multiple sclerosis	0.00013	0.0188	CcSEcCtD
Trifluridine—TYMS—midbrain—multiple sclerosis	0.000121	0.0598	CbGeAlD
Trifluridine—TYMP—nervous system—multiple sclerosis	0.000115	0.0573	CbGeAlD
Trifluridine—TYMP—central nervous system—multiple sclerosis	0.000111	0.0552	CbGeAlD
Trifluridine—TYMP—cerebellum—multiple sclerosis	0.000109	0.0539	CbGeAlD
Trifluridine—TYMS—nervous system—multiple sclerosis	9.91e-05	0.0492	CbGeAlD
Trifluridine—TYMS—central nervous system—multiple sclerosis	9.54e-05	0.0473	CbGeAlD
Trifluridine—Pain—Cladribine—multiple sclerosis	9.51e-05	0.0138	CcSEcCtD
Trifluridine—TYMS—cerebellum—multiple sclerosis	9.32e-05	0.0463	CbGeAlD
Trifluridine—TYMP—brain—multiple sclerosis	8.83e-05	0.0438	CbGeAlD
Trifluridine—SLC22A6—brain—multiple sclerosis	8.5e-05	0.0422	CbGeAlD
Trifluridine—TYMS—E2F transcription factor network—RRM1—multiple sclerosis	8.47e-05	0.0306	CbGpPWpGaD
Trifluridine—Vision blurred—Mitoxantrone—multiple sclerosis	8.44e-05	0.0123	CcSEcCtD
Trifluridine—Hypersensitivity—Cladribine—multiple sclerosis	8.2e-05	0.0119	CcSEcCtD
Trifluridine—TYMS—Nucleotide metabolism—RRM1—multiple sclerosis	8.03e-05	0.029	CbGpPWpGaD
Trifluridine—TYMS—brain—multiple sclerosis	7.57e-05	0.0376	CbGeAlD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	7.36e-05	0.0266	CbGpPWpGaD
Trifluridine—Zidovudine—ALB—multiple sclerosis	7.27e-05	0.136	CrCbGaD
Trifluridine—Vision blurred—Prednisolone—multiple sclerosis	6.93e-05	0.0101	CcSEcCtD
Trifluridine—Hypersensitivity—Azathioprine—multiple sclerosis	6.67e-05	0.00969	CcSEcCtD
Trifluridine—Nausea—Cladribine—multiple sclerosis	6.61e-05	0.00961	CcSEcCtD
Trifluridine—Pain—Mitoxantrone—multiple sclerosis	6.25e-05	0.00909	CcSEcCtD
Trifluridine—TYMP—Bladder Cancer—MYC—multiple sclerosis	5.64e-05	0.0204	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—MAPK1—multiple sclerosis	5.51e-05	0.0199	CbGpPWpGaD
Trifluridine—Hypersensitivity—Mitoxantrone—multiple sclerosis	5.39e-05	0.00783	CcSEcCtD
Trifluridine—Nausea—Azathioprine—multiple sclerosis	5.37e-05	0.00781	CcSEcCtD
Trifluridine—Pain—Prednisolone—multiple sclerosis	5.13e-05	0.00746	CcSEcCtD
Trifluridine—Vision blurred—Prednisone—multiple sclerosis	5.03e-05	0.00732	CcSEcCtD
Trifluridine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	4.92e-05	0.0178	CbGpPWpGaD
Trifluridine—TYMS—Azacitidine—Cladribine—multiple sclerosis	4.74e-05	0.0399	CbGdCrCtD
Trifluridine—Pain—Triamcinolone—multiple sclerosis	4.72e-05	0.00686	CcSEcCtD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—MMP9—multiple sclerosis	4.66e-05	0.0168	CbGpPWpGaD
Trifluridine—Hypersensitivity—Prednisolone—multiple sclerosis	4.42e-05	0.00643	CcSEcCtD
Trifluridine—Nausea—Mitoxantrone—multiple sclerosis	4.34e-05	0.00632	CcSEcCtD
Trifluridine—Pain—Dexamethasone—multiple sclerosis	4.28e-05	0.00622	CcSEcCtD
Trifluridine—Pain—Betamethasone—multiple sclerosis	4.28e-05	0.00622	CcSEcCtD
Trifluridine—Vision blurred—Methotrexate—multiple sclerosis	4.21e-05	0.00612	CcSEcCtD
Trifluridine—TK1—E2F transcription factor network—MYC—multiple sclerosis	4.1e-05	0.0148	CbGpPWpGaD
Trifluridine—Hypersensitivity—Triamcinolone—multiple sclerosis	4.07e-05	0.00591	CcSEcCtD
Trifluridine—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.06e-05	0.0059	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	3.92e-05	0.0142	CbGpPWpGaD
Trifluridine—TK1—Metabolism—SRM—multiple sclerosis	3.85e-05	0.0139	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—MYC—multiple sclerosis	3.85e-05	0.0139	CbGpPWpGaD
Trifluridine—Nausea—Prednisolone—multiple sclerosis	3.56e-05	0.00518	CcSEcCtD
Trifluridine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	3.44e-05	0.0124	CbGpPWpGaD
Trifluridine—Nausea—Triamcinolone—multiple sclerosis	3.28e-05	0.00477	CcSEcCtD
Trifluridine—Nausea—Methylprednisolone—multiple sclerosis	3.27e-05	0.00475	CcSEcCtD
Trifluridine—Hypersensitivity—Prednisone—multiple sclerosis	3.21e-05	0.00467	CcSEcCtD
Trifluridine—Pain—Methotrexate—multiple sclerosis	3.12e-05	0.00453	CcSEcCtD
Trifluridine—TYMS—Clobetasol propionate—Methylprednisolone—multiple sclerosis	3.05e-05	0.0256	CbGdCrCtD
Trifluridine—TYMS—Flunisolide—Methylprednisolone—multiple sclerosis	3.01e-05	0.0253	CbGdCrCtD
Trifluridine—TYMS—Clobetasol propionate—Betamethasone—multiple sclerosis	3e-05	0.0252	CbGdCrCtD
Trifluridine—TYMS—Clobetasol propionate—Dexamethasone—multiple sclerosis	3e-05	0.0252	CbGdCrCtD
Trifluridine—TYMS—Triamcinolone—Methylprednisolone—multiple sclerosis	2.98e-05	0.025	CbGdCrCtD
Trifluridine—Nausea—Dexamethasone—multiple sclerosis	2.97e-05	0.00432	CcSEcCtD
Trifluridine—Nausea—Betamethasone—multiple sclerosis	2.97e-05	0.00432	CcSEcCtD
Trifluridine—TYMS—Flunisolide—Dexamethasone—multiple sclerosis	2.96e-05	0.0249	CbGdCrCtD
Trifluridine—TYMS—Flunisolide—Betamethasone—multiple sclerosis	2.96e-05	0.0249	CbGdCrCtD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	2.95e-05	0.0107	CbGpPWpGaD
Trifluridine—TYMS—Clobetasol propionate—Triamcinolone—multiple sclerosis	2.93e-05	0.0246	CbGdCrCtD
Trifluridine—TYMS—Triamcinolone—Dexamethasone—multiple sclerosis	2.93e-05	0.0246	CbGdCrCtD
Trifluridine—TYMS—Triamcinolone—Betamethasone—multiple sclerosis	2.93e-05	0.0246	CbGdCrCtD
Trifluridine—TYMS—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	2.9e-05	0.0244	CbGdCrCtD
Trifluridine—TYMS—Flunisolide—Triamcinolone—multiple sclerosis	2.89e-05	0.0243	CbGdCrCtD
Trifluridine—TYMS—Fluticasone Propionate—Dexamethasone—multiple sclerosis	2.86e-05	0.024	CbGdCrCtD
Trifluridine—TYMS—Fluticasone Propionate—Betamethasone—multiple sclerosis	2.86e-05	0.024	CbGdCrCtD
Trifluridine—TYMS—Fluticasone Propionate—Triamcinolone—multiple sclerosis	2.79e-05	0.0235	CbGdCrCtD
Trifluridine—TYMS—Clobetasol propionate—Prednisone—multiple sclerosis	2.78e-05	0.0234	CbGdCrCtD
Trifluridine—TYMS—Flunisolide—Prednisone—multiple sclerosis	2.74e-05	0.0231	CbGdCrCtD
Trifluridine—TYMS—Diflorasone—Methylprednisolone—multiple sclerosis	2.74e-05	0.0231	CbGdCrCtD
Trifluridine—TYMS—Triamcinolone—Prednisone—multiple sclerosis	2.72e-05	0.0228	CbGdCrCtD
Trifluridine—TK1—Metabolism—CYP27B1—multiple sclerosis	2.72e-05	0.00981	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYP24A1—multiple sclerosis	2.72e-05	0.00981	CbGpPWpGaD
Trifluridine—TYMS—Clobetasol propionate—Prednisolone—multiple sclerosis	2.71e-05	0.0228	CbGdCrCtD
Trifluridine—TYMS—Diflorasone—Betamethasone—multiple sclerosis	2.7e-05	0.0227	CbGdCrCtD
Trifluridine—TYMS—Diflorasone—Dexamethasone—multiple sclerosis	2.7e-05	0.0227	CbGdCrCtD
Trifluridine—Hypersensitivity—Methotrexate—multiple sclerosis	2.68e-05	0.0039	CcSEcCtD
Trifluridine—TYMS—Flunisolide—Prednisolone—multiple sclerosis	2.68e-05	0.0225	CbGdCrCtD
Trifluridine—TYMP—Metabolism—SRM—multiple sclerosis	2.67e-05	0.00965	CbGpPWpGaD
Trifluridine—TYMS—Triamcinolone—Prednisolone—multiple sclerosis	2.65e-05	0.0223	CbGdCrCtD
Trifluridine—TYMS—Diflorasone—Triamcinolone—multiple sclerosis	2.64e-05	0.0222	CbGdCrCtD
Trifluridine—Nausea—Prednisone—multiple sclerosis	2.59e-05	0.00377	CcSEcCtD
Trifluridine—TYMS—Diflorasone—Prednisone—multiple sclerosis	2.5e-05	0.021	CbGdCrCtD
Trifluridine—TK1—Metabolism—GPC5—multiple sclerosis	2.48e-05	0.00897	CbGpPWpGaD
Trifluridine—TYMS—Diflorasone—Prednisolone—multiple sclerosis	2.44e-05	0.0205	CbGdCrCtD
Trifluridine—TYMS—Budesonide—Methylprednisolone—multiple sclerosis	2.4e-05	0.0202	CbGdCrCtD
Trifluridine—TYMS—Budesonide—Betamethasone—multiple sclerosis	2.37e-05	0.0199	CbGdCrCtD
Trifluridine—TYMS—Budesonide—Dexamethasone—multiple sclerosis	2.37e-05	0.0199	CbGdCrCtD
Trifluridine—TYMS—Budesonide—Triamcinolone—multiple sclerosis	2.31e-05	0.0194	CbGdCrCtD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	2.23e-05	0.00807	CbGpPWpGaD
Trifluridine—TYMS—Budesonide—Prednisone—multiple sclerosis	2.19e-05	0.0184	CbGdCrCtD
Trifluridine—Nausea—Methotrexate—multiple sclerosis	2.16e-05	0.00315	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.15e-05	0.00777	CbGpPWpGaD
Trifluridine—TYMS—Budesonide—Prednisolone—multiple sclerosis	2.14e-05	0.018	CbGdCrCtD
Trifluridine—TYMS—Danazol—Prednisone—multiple sclerosis	2.1e-05	0.0177	CbGdCrCtD
Trifluridine—TK1—Metabolism—RRM1—multiple sclerosis	2.06e-05	0.00744	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP27B1—multiple sclerosis	1.88e-05	0.0068	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP24A1—multiple sclerosis	1.88e-05	0.0068	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.73e-05	0.00624	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GPC5—multiple sclerosis	1.72e-05	0.00622	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	1.56e-05	0.00564	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.5e-05	0.00541	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.48e-05	0.00534	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—MYC—multiple sclerosis	1.45e-05	0.00525	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—RRM1—multiple sclerosis	1.43e-05	0.00515	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—FAS—multiple sclerosis	1.42e-05	0.00512	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SRM—multiple sclerosis	1.37e-05	0.00494	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	1.26e-05	0.00456	CbGpPWpGaD
Trifluridine—TK1—Metabolism—BCHE—multiple sclerosis	1.18e-05	0.00427	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.14e-05	0.0041	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—MYC—multiple sclerosis	1.05e-05	0.00381	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP27B1—multiple sclerosis	9.63e-06	0.00348	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP24A1—multiple sclerosis	9.63e-06	0.00348	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.97e-06	0.00324	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—MYC—multiple sclerosis	8.89e-06	0.00321	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GPC5—multiple sclerosis	8.81e-06	0.00318	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—BCHE—multiple sclerosis	8.19e-06	0.00296	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.93e-06	0.00287	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—RRM1—multiple sclerosis	7.3e-06	0.00264	CbGpPWpGaD
Trifluridine—TK1—Metabolism—APOE—multiple sclerosis	7.11e-06	0.00257	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.73e-06	0.00243	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.72e-06	0.00243	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.59e-06	0.00238	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.27e-06	0.00227	CbGpPWpGaD
Trifluridine—TK1—Metabolism—POMC—multiple sclerosis	6.11e-06	0.00221	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.62e-06	0.00203	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ALB—multiple sclerosis	5.57e-06	0.00201	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—APOE—multiple sclerosis	4.93e-06	0.00178	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—IL6—multiple sclerosis	4.86e-06	0.00176	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—POMC—multiple sclerosis	4.23e-06	0.00153	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—BCHE—multiple sclerosis	4.19e-06	0.00151	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ALB—multiple sclerosis	3.86e-06	0.00139	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MYC—multiple sclerosis	3.26e-06	0.00118	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	3.19e-06	0.00115	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MYC—multiple sclerosis	2.91e-06	0.00105	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.86e-06	0.00103	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MAPK1—multiple sclerosis	2.85e-06	0.00103	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—APOE—multiple sclerosis	2.52e-06	0.000911	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—POMC—multiple sclerosis	2.17e-06	0.000783	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ALB—multiple sclerosis	1.97e-06	0.000714	CbGpPWpGaD
